Kelman-Lazarov Inc’s Morgan Stanley Emerging Mkts Fd MSF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-10,250
Closed -$160K 105
2018
Q3
$160K Sell
10,250
-4,200
-29% -$67.2K 0.09% 95
2018
Q2
$235K Sell
14,450
-150
-1% -$2.59K 0.13% 100
2018
Q1
$269K Buy
14,600
+1,500
+11% +$28.2K 0.14% 95
2017
Q4
$234K Buy
13,100
+2,150
+20% +$37.7K 0.12% 106
2017
Q3
$190K Hold
10,950
0.1% 109
2017
Q2
$18K Sell
10,950
-250
-2% -$3.95K 0.01% 123
2017
Q1
$165K Hold
11,200
0.11% 99
2016
Q4
$148K Buy
11,200
+1,200
+12% +$16.5K 0.08% 116
2016
Q3
$145K Hold
10,000
0.08% 121
2016
Q2
$134K Hold
10,000
0.08% 126
2016
Q1
$132K Buy
+10,000
New +$121K 0.08% 132

Other funds holding MSF

Kelman-Lazarov Inc's MSF Position: Q4 2018 in Review

Kelman-Lazarov Inc sold out of Morgan Stanley Emerging Mkts Fd (MSF) in Q4 2018, closing a stake of 10,250 shares — an estimated $160K sold.

Kelman-Lazarov Inc first reported a position in MSF in Q1 2016 and held it in 11 quarters. The position peaked at $269K in Q1 2018. 41 funds tracked by Wall St. Rank hold MSF as of Q4 2018.

  • Kelman-Lazarov Inc reported no remaining Morgan Stanley Emerging Mkts Fd position as of Q4 2018 after selling out during the quarter.
  • Kelman-Lazarov Inc sold 10,250 Morgan Stanley Emerging Mkts Fd shares in Q4 2018, an estimated $160K.
  • Kelman-Lazarov Inc first reported a position in Morgan Stanley Emerging Mkts Fd in Q1 2016 and held it in 11 quarters.
  • Kelman-Lazarov Inc's Morgan Stanley Emerging Mkts Fd position peaked at $269K in Q1 2018.
  • 41 funds tracked by Wall St. Rank held Morgan Stanley Emerging Mkts Fd as of Q4 2018.

Based on Kelman-Lazarov Inc's 13F filing for Q4 2018, filed 11 Feb 2019.